Inhalation Product Technology Centre (IPTC) from H&T Presspart
Supporting the strategic projects of H&T Presspart and our customers
H&T Presspart have further expanded our research and development capabilities with the creation of the Inhalation Product Technology Centre (IPTC).
As the world’s leading manufacturer of components for metered dose inhalers, including MDI canisters and injection-moulded MDI plastic actuators, the Inhalation Product Technology Centre, supports the strategic projects of H&T Presspart and most importantly our customers.
Our IPTC delivers the capabilities to support new product developments and strategic initiatives with our customers. H&T Presspart has an in-depth technical understanding of the products we manufacture and assemble and IPTC enhances these capabilities and delivers a customer focused device development and drug related performance understanding.
Key Capabilities of IPTC include:
- Inhalation Device Design, Concept and Development
- Device customisation and enhancement to meet formulation requirements
- Device performance / interaction studies with the drug product
- Device meteorology and specification development
- Component / device evaluation, screening and optimization
- Inhalation product testing support
- Multi region regulatory support
The Inhalation Product Development Centre is headed by Ameet Sule, who is based at H&T Presspart Blackburn at the IPTC headquarters, which includes extensive offices, research and laboratory facilities as well as a dedicated team working within the Inhalation Product Technology Centre.
Ameet holds a Masters in Chemistry from Mumbai University, and joined the company from Lupin, where he held the position of Director Pulmonary Research. Ameet is a R&D professional with over 19 years of experience encompassing the development of MDI components, formulations, analytical methods and drug products.